Kytril: Exit Page

Click here for Kytril International

Tell A Friend

Home

Site Map

Safety Information

Product Information


	Just Type in your Question and click "Ask KYTRIL"

Cancer Patient

Caring for a Cancer Patient

Healthcare Professionals


Exit Page

	You are now leaving the Kytril.com Web site. Links to all external sites are provided as a resource to our visitors. Genentech USA, Inc. (“Genentech”) accepts no responsibility for the content of these sites. Genentech does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Genentech. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Genentech prescription medication. Click here to go back Click here to continue

The most frequently reported clinical adverse events occurring in >5% of patients receiving Kytril were headache, constipation, asthenia, diarrhea, abdominal pain*, dyspepsia*, pain^†, anemia^†, fever^† and elevated hepatic enzymes^†. The use of Kytril in patients following abdominal surgery or in patients with chemotherapy induced nausea and vomiting may mask progressive ileus and/or gastric distention.

*Associated with Kytril Tablets only.
^†Associated with Kytril Injection for postoperative nausea and vomiting only.